TRIEX
Price
$23.97
Change
-$0.33 (-1.36%)
Updated
Nov 8 closing price
VGTSX
Price
$19.97
Change
-$0.27 (-1.33%)
Updated
Nov 8 closing price
Ad is loading...

TRIEX vs VGTSX

Header iconTRIEX vs VGTSX Comparison
Open Charts TRIEX vs VGTSXBanner chart's image
Nuveen International Eq Idx Retire
Price$23.97
Change-$0.33 (-1.36%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$19.97
Change-$0.27 (-1.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TRIEX vs VGTSX Comparison Chart
Loading...
VS
TRIEX vs. VGTSX commentary
Nov 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRIEX is a StrongSell and VGTSX is a StrongSell.

FUNDAMENTALS
Fundamentals
VGTSX has more cash in the bank: 442B vs. TRIEX (27.3B). VGTSX pays higher dividends than TRIEX: VGTSX (3.20) vs TRIEX (2.67). TRIEX was incepted earlier than VGTSX: TRIEX (22 years) vs VGTSX (29 years). TRIEX is a more actively managed with annual turnover of: 5.00 vs. VGTSX (4.00). TRIEX (0) and VGTSX (0) have matching initial minimum investment requirements. TRIEX annual gain was more profitable for investors over the last year : 18.53 vs. VGTSX (17.61). TRIEX return over 5 years is better than : 29.85 vs. VGTSX (19.10).
TRIEXVGTSXTRIEX / VGTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years29 years-
Gain YTD6.8187.67489%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B442B6%
Annual Yield % from dividends2.673.2083%
Returns for 1 year18.5317.61105%
Returns for 3 years3.83-3.15-122%
Returns for 5 years29.8519.10156%
Returns for 10 years45.3633.86134%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WTBA23.930.44
+1.87%
West Bancorporation
WINA410.464.48
+1.10%
Winmark Corp
BMI223.470.22
+0.10%
Badger Meter
CTVA58.33-0.31
-0.53%
Corteva
MRKR4.14-0.15
-3.50%
Marker Therapeutics